Document is current
Any future updates will be listed below
-
Authors
Braun, Julian
Loyal, Lucie
Frentsch, Marco
Wendisch, Daniel https://orcid.org/0000-0003-1968-5751
Georg, Philipp
Kurth, Florian https://orcid.org/0000-0002-3807-473X
Hippenstiel, Stefan https://orcid.org/0000-0002-5146-1064
Dingeldey, Manuela
Kruse, Beate
Fauchere, Florent https://orcid.org/0000-0002-1955-6362
Baysal, Emre
Mangold, Maike
Henze, Larissa
Lauster, Roland
Mall, Marcus A.
Beyer, Kirsten
Röhmel, Jobst
Voigt, Sebastian https://orcid.org/0000-0003-1544-9903
Schmitz, Jürgen
Miltenyi, Stefan
Demuth, Ilja
Müller, Marcel A. https://orcid.org/0000-0003-2242-5117
Hocke, Andreas
Witzenrath, Martin
Suttorp, Norbert
Kern, Florian https://orcid.org/0000-0002-0368-8408
Reimer, Ulf
Wenschuh, Holger
Drosten, Christian https://orcid.org/0000-0001-7923-0519
Corman, Victor M. https://orcid.org/0000-0002-3605-0136
Giesecke-Thiel, Claudia https://orcid.org/0000-0002-5927-7018
Sander, Leif Erik https://orcid.org/0000-0002-0476-9947
Thiel, Andreas https://orcid.org/0000-0002-5515-4002
- License Information
-
More Information
Article History
Received: 9 April 2020
Accepted: 22 July 2020
First Online: 29 July 2020
Competing interests
: F. Kern, U.R. and H.W. are employed at JPT Peptide Technologies, who have provided peptide pools for this work. F. Kern also part-owns and is inventor on a patent describing the use of overlapping peptide pools for the stimulation of T cells. Until this patent expires, he will receive royalties on JPT PepMix sales. J.S. and S.M. are employed at Miltenyi Biotec, who provided reagents and devices for this study. All other authors declare no competing interests.
Free to read: This content has been made available to all.
